Association between a defective CCR-5 gene and progression to disease in HIV infection. 1998

P Balfe, and Y Churcher, and M Penny, and P J Easterbrook, and R L Goodall, and S Galpin, and F Gotch, and R S Daniels, and J A McKeating
Department of Virology, UCLMS, London, UK. p.balfe@ucl.ac.uk

We measured the effect(s) of CCR-5 genotype on disease progression by studying the frequency of a defective CCR-5 delta32 allele within a cohort of long-term infected individuals. An elevated frequency of CCR-5 delta32 heterozygotes within the cohort compared with a control population of blood donors was observed. An association between progression rate and CCR-5 delta32 heterozygosity was observed. Furthermore, analysis of proviral DNA V3 sequences from a subset of the cohort predicted that the majority of individuals (39 of 44) were infected with viruses predicted to utilize the beta-chemokine receptor CCR-5. The marked association between CCR-5 genotype and disease progression observed in this study may be a consequence of the predicted low frequency of CXCR-4-utilizing viruses present within the selected cohort.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D006579 Heterozygote An individual having different alleles at one or more loci regarding a specific character. Carriers, Genetic,Genetic Carriers,Carrier, Genetic,Genetic Carrier,Heterozygotes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000483 Alleles Variant forms of the same gene, occupying the same locus on homologous CHROMOSOMES, and governing the variants in production of the same gene product. Allelomorphs,Allele,Allelomorph
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D015331 Cohort Studies Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics. Birth Cohort Studies,Birth Cohort Study,Closed Cohort Studies,Cohort Analysis,Concurrent Studies,Historical Cohort Studies,Incidence Studies,Analysis, Cohort,Cohort Studies, Closed,Cohort Studies, Historical,Studies, Closed Cohort,Studies, Concurrent,Studies, Historical Cohort,Analyses, Cohort,Closed Cohort Study,Cohort Analyses,Cohort Studies, Birth,Cohort Study,Cohort Study, Birth,Cohort Study, Closed,Cohort Study, Historical,Concurrent Study,Historical Cohort Study,Incidence Study,Studies, Birth Cohort,Studies, Cohort,Studies, Incidence,Study, Birth Cohort,Study, Closed Cohort,Study, Cohort,Study, Concurrent,Study, Historical Cohort,Study, Incidence
D015483 HIV Antibodies Antibodies reactive with HIV ANTIGENS. AIDS Antibodies,HIV-Associated Antibodies,HTLV-III Antibodies,HTLV-III-LAV Antibodies,LAV Antibodies,Lymphadenopathy-Associated Antibodies,T-Lymphotropic Virus Type III Antibodies, Human,HIV Associated Antibodies,HTLV III Antibodies,HTLV III LAV Antibodies,Lymphadenopathy Associated Antibodies,T Lymphotropic Virus Type III Antibodies, Human,Antibodies, AIDS,Antibodies, HIV,Antibodies, HIV Associated,Antibodies, HIV-Associated,Antibodies, HTLV III,Antibodies, HTLV-III,Antibodies, HTLV-III-LAV,Antibodies, LAV,Antibodies, Lymphadenopathy Associated,Antibodies, Lymphadenopathy-Associated
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human

Related Publications

P Balfe, and Y Churcher, and M Penny, and P J Easterbrook, and R L Goodall, and S Galpin, and F Gotch, and R S Daniels, and J A McKeating
March 1997, Nature medicine,
P Balfe, and Y Churcher, and M Penny, and P J Easterbrook, and R L Goodall, and S Galpin, and F Gotch, and R S Daniels, and J A McKeating
March 1997, Lancet (London, England),
P Balfe, and Y Churcher, and M Penny, and P J Easterbrook, and R L Goodall, and S Galpin, and F Gotch, and R S Daniels, and J A McKeating
January 1999, Emerging infectious diseases,
P Balfe, and Y Churcher, and M Penny, and P J Easterbrook, and R L Goodall, and S Galpin, and F Gotch, and R S Daniels, and J A McKeating
April 2019, Journal of cellular and molecular medicine,
P Balfe, and Y Churcher, and M Penny, and P J Easterbrook, and R L Goodall, and S Galpin, and F Gotch, and R S Daniels, and J A McKeating
May 1998, AIDS (London, England),
P Balfe, and Y Churcher, and M Penny, and P J Easterbrook, and R L Goodall, and S Galpin, and F Gotch, and R S Daniels, and J A McKeating
March 1999, AIDS (London, England),
P Balfe, and Y Churcher, and M Penny, and P J Easterbrook, and R L Goodall, and S Galpin, and F Gotch, and R S Daniels, and J A McKeating
August 1996, Nature,
P Balfe, and Y Churcher, and M Penny, and P J Easterbrook, and R L Goodall, and S Galpin, and F Gotch, and R S Daniels, and J A McKeating
October 2000, British journal of haematology,
P Balfe, and Y Churcher, and M Penny, and P J Easterbrook, and R L Goodall, and S Galpin, and F Gotch, and R S Daniels, and J A McKeating
December 1998, AIDS (London, England),
P Balfe, and Y Churcher, and M Penny, and P J Easterbrook, and R L Goodall, and S Galpin, and F Gotch, and R S Daniels, and J A McKeating
September 2011, AIDS (London, England),
Copied contents to your clipboard!